Research.Patient.info
Select Advanced Solid Tumors research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE1, PHASE2
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
This study is testing a new medicine called brenetafusp for people with certain advanced solid cancers that haven't responded to other treatments. It checks how safe and effective brenetafusp is, both alone and with other common cancer drugs.
United States · Australia · Austria - recruitingPHASE1
First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors
This study is testing a new experimental medicine, CDR404, for hard-to-treat solid cancers that have a specific marker called MAGE-A4. It's the first time CDR404 is being used in people, and doctors want to see if it's safe and if it can help fight the cancer.
United States · Belgium · Denmark